Quick Answer
Bacteriostatic water is sterile water preserved with 0.9% benzyl alcohol. It is the standard diluent for reconstituting lyophilised research peptides because the preservative suppresses microbial growth, letting an opened multi-dose vial stay in use for up to 28 days. The volume added is chosen relative to the peptide mass in the vial to produce a workable concentration for the study design.
Bacteriostatic water is a small, unassuming 30 mL vial that turns a freeze-dried powder into a stable solution for laboratory use. This guide covers what it actually is, why the preservative matters, and how research laboratories select the appropriate volume.
What is Bacteriostatic Water?
Bacteriostatic water for injection (BWFI) is sterile, non-pyrogenic water containing 0.9% (9 mg/mL) benzyl alcohol as an antimicrobial preservative, as set out in the US product label. It is supplied in multi-dose vials, most commonly 30 mL, sealed with a butyl rubber stopper and aluminium overseal. The USP monograph specifies purity, sterility, and endotoxin limits.
The critical ingredient is the benzyl alcohol. It is bacteriostatic, meaning it inhibits the growth of bacteria rather than killing them outright (which would be bactericidal). That is sufficient to keep a punctured vial stable for repeated draws over several weeks.
Bacteriostatic Water vs Sterile Water for Injection
The two look identical in the vial and are often confused. The difference is the preservative.
| Property | Bacteriostatic Water | Sterile Water for Injection |
|---|---|---|
| Preservative | 0.9% benzyl alcohol | None |
| Format | Multi-dose, typically 30 mL | Single-dose, typically 10 mL |
| Stability after opening | Up to 28 days after first puncture | Discard immediately after use |
| Use case | Multi-dose peptide reconstitution | Single-use dilution; bulk packs for pharmacy compounding |
For a vial that will be drawn from more than once, bacteriostatic water is the appropriate choice. Sterile water for injection is appropriate only when the entire reconstituted volume is used at once and the remainder discarded.
Why the Preservative Matters
Every time a needle punctures a vial stopper, there is a small risk of introducing skin flora or airborne organisms. In a survey of 227 opened multi-dose vials in one hospital, Mattner and Gastmeier (2004) found a contamination rate of 0.9%, with a common skin bacterium. What happens to such organisms depends on the solution: when Highsmith et al. (1982) added microbes to eight medicines from multi-dose vials, some killed them within 24 hours, while others let some survive and one supported growth under certain conditions. Benzyl alcohol is one of the two most common preservatives in injectable peptide and protein products, according to a review by Meyer et al. (2007), but a preservative limits growth rather than guaranteeing sterility: US CDC injection-safety guidance notes that it does not give complete protection against bacterial contamination.
The 28-day limit is set out in the same CDC guidance: once opened, a multi-dose vial should be dated and discarded within 28 days unless the manufacturer states another date. It matches the length of the USP <51> antimicrobial effectiveness test, which challenges a preserved injection with organisms including Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans, and requires bacterial counts to fall by day 14 and not rise again by day 28. The test does not look beyond 28 days.
Determining Reconstitution Volume
The volume added sets the concentration, calculated as concentration (mg/mL) equals peptide mass (mg) divided by water volume (mL). Laboratories select the volume that produces a concentration appropriate to the assay or study design.
Reconstitution Technique in Brief
- Allow both vials to reach room temperature.
- Wipe both stoppers with an alcohol swab and let dry.
- Draw the calculated volume of bacteriostatic water into a syringe.
- Insert the needle at an angle and release the water slowly down the inside wall of the peptide vial, rather than directly onto the powder.
- Swirl gently in a circular motion until the powder dissolves. Do not shake.
- Label the vial with peptide name, concentration, and reconstitution date.
- Store upright at 2 to 8°C.
Storage of Bacteriostatic Water
- Before opening: store at controlled room temperature (the US product label specifies 20 to 25°C), away from direct light, and use by the expiry date printed on the label.
- After first puncture: refrigeration at 2 to 8°C is standard laboratory practice. Discard 28 days after first puncture, or sooner if turbidity or particulates appear.
- Do not freeze. Freezing can crack the glass and compromise the seal.
Formulation Considerations
Benzyl alcohol is the reason bacteriostatic water functions as a multi-dose diluent, and also carries recognised formulation limits. Two points are relevant to laboratory context:
- Benzyl alcohol is contraindicated in neonates, where it has been associated with the "gasping syndrome" described in the clinical literature by Gershanik et al. (1982). A 1982 CDC report linked 16 deaths of premature infants to catheter flush solutions preserved with benzyl alcohol. This is why the product label states that only preservative-free sterile water for injection should be used to prepare or dilute medicines for neonates.
- At high total amounts, benzyl alcohol can cause metabolic acidosis: the affected infants received repeated daily flushes, and the liver pathway that clears its breakdown product (benzoic acid) may not be well developed in premature infants. This is not applicable to laboratory-scale reconstitution volumes used in research settings.
Bacteriostatic water is a laboratory reagent in the research context. It is not intended for human or veterinary use.
Where to Source Bacteriostatic Water
Retail pharmacies rarely carry the 30 mL multi-dose format because it is not a common outpatient dispense. Research suppliers stock it as a matter of course. Peptx supplies USP-grade bacteriostatic water alongside its peptide catalogue, in 30 mL sterile multi-dose vials, factory-direct with tracked worldwide dispatch.
Full product details and pricing are on the bacteriostatic water product page.
Related Reading
References
- Centers for Disease Control (CDC). (1982). Neonatal deaths associated with use of benzyl alcohol--United States. Morbidity and Mortality Weekly Report. PubMed 6810084
- Gershanik J, et al. (1982). The gasping syndrome and benzyl alcohol poisoning. New England Journal of Medicine. PubMed 7133084
- Highsmith AK, et al. (1982). Growth of nosocomial pathogens in multiple-dose parenteral medication vials. Journal of Clinical Microbiology. PubMed 7050144
- Mattner F, Gastmeier P. (2004). Bacterial contamination of multiple-dose vials: a prevalence study. American Journal of Infection Control. PubMed 14755229
- Meyer BK, et al. (2007). Antimicrobial preservative use in parenteral products: past and present. Journal of Pharmaceutical Sciences. PubMed 17722087